药品信息:
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201411422542120.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- 部分中文索利塔-T2号输液处方资料(仅供参考)
治疗类名称
注入电解液(脱水供给液体)
商标名称
索利塔-T2号输液(200ml)中
组成
这种药物包含下列组件。
在一个组件(200毫升)
氯化钠0.54克
氯化钾0.298克
0.062克磷酸二氢钠
磷酸氢钠水合物0.574克
葡萄糖6.4克
L-乳酸钠0.448克
一种添加剂(200毫升)中
L-乳酸(pH调节剂)适量
热量
26kcal(200毫升中)
电解质浓度(毫当量/升)
Na + 84
ķ + 20
氯- 66
L-乳酸- 20 ※
量(mmol / L)磷酸10
L-乳酸作为※添加剂(L-乳酸-浓度:8mEq / L),因为它包含了L-乳酸这种药物的-浓度为28mEq / L。
禁忌
很可能加剧患者乳酸血症[乳酸血。
还有就是要加重高钾血症,少尿,阿狄森氏病,严重烧伤,氮质血症的病人[高钾血症,或造成危险。
有一个风险,加重[高磷血症,低钙血症患者高血磷,低血钙,甲状旁腺功能减退,或原因。
效果或疗效
供应,水电解质手术前后和脱水纠正
我静脉滴注成人一次500~1000毫升。如果300~500毫升每成人1小时后
细心管理
存在引起水电解质异常患者的无高钾血症肾功能衰竭,或恶化的风险。
有心脏衰竭是由钠和[水心脏衰竭患者的负担加重的危险。
水和电解质异常,则有可能会导致血液中乳酸的上升,或加剧患者严重肝损伤。
有一种可能性,引起水,电解质异常,或加重患者尿量减少尿路梗阻。]
甲升高的糖尿病患者的血糖水平,它是造成水,电解质异常,或恶化的风险。
Brand Name
Solita-T2 No. infusion (200mL)
Composition
This drug contains the following components.
One component (200mL) in
Sodium chloride 0.54g
potassium chloride 0.298g
0.062g sodium dihydrogen phosphate
sodium hydrogen phosphate hydrate 0.574g
glucose 6.4 g
L-lactic acid sodium 0.448g
One additive (200mL) in
L-lactic acid (pH modifier)
appropriate amount
Amount of heat
26kcal (200mL in)
Electrolyte concentration (mEq / L)
Na + 84
K + 20
Cl - 66
L-Lactate - 20 ※
(mmol / L) Phosphate 10
L-lactic acid as ※ additives (L-Lactate - Concentration: 8mEq / L) because it contains a, L-Lactate of this drug - concentration is 28mEq / L.
Contraindication
Is likely to exacerbate [lactic acid blood of patients lactic acid blood disease. ]
There is a risk to exacerbation hyperkalemia, oliguria, Addison's disease, severe burns, azotemia patients [hyperkalemia, or cause. ]
There is a risk to exacerbation [hyperphosphatemia, hypocalcemia patient hyperphosphatemia, hypocalcemia, hypoparathyroidism, or cause. ]
Effect or efficacy
Supply, the correction of the water-electrolyte before and after surgery and dehydration
I intravenous infusion adult, once 500 ~ 1000mL. If 300 ~ 500mL 1 hour per adult, children,
Careful administration
There is a risk of causing the water-electrolyte abnormalities patients with renal failure without hyperkalemia, or exacerbation.
There is a risk of heart failure is exacerbated by the load of sodium and [Water patients with heart failure.
[Water and electrolyte abnormalities, there is a possibility to cause a rise in blood lactate, or exacerbate patients with severe liver damage.
There is a possibility to cause the water, electrolyte abnormalities, or exacerbate patients urine volume is reduced by obstructive uropathy.
A rise of the blood sugar levels of diabetic patients, the risk of it being cause water, electrolyte abnormalities, or exacerbated. |